admin
The Department of Health and Human Services announced this week that it has opened a clinic at the NIH Clinical Center in Bethesda to evaluate and study patients who report health problems after vaccination. The move comes with a package of policy changes — from a push to make electronic health records capture vaccine events to a CMS proposal to reimburse doctors for filing VAERS reports — and it signals a real change in how the federal government will handle alleged vaccine injuries.
HHS opens an NIH clinic to study vaccine injuries
The new NIH clinic is billed as a place where clinicians will both treat patients and collect data that could help answer whether certain illnesses or injuries are linked to vaccines. HHS Secretary Robert F. Kennedy, Jr. framed it bluntly: “We must listen to patients and families who report vaccine injuries.” The announcement also includes plans to modernize the Vaccine Adverse Event Reporting System (VAERS), require electronic health records to follow vaccine‑related events across providers, and to seek Medicare reimbursement for the time doctors spend filing VAERS reports.
Why this matters for vaccine safety and patient care
This is the first time a federal program has explicitly created a clinic whose mission includes both care and research for people reporting post‑vaccine problems. If done right, better data collection, easier VAERS reporting, and longitudinal electronic records could help researchers separate true safety signals from coincidence. That matters because VAERS is a passive system: it collects reports of things that happen after vaccination but does not, on its own, prove causation. Improving the quality of reports and adding clinical follow‑up could reduce confusion and improve public confidence — assuming the science is front and center.
Big questions left unanswered — and valid concerns
But the announcement left several practical questions hanging. Who will qualify for care at the NIH clinic? How will cases be selected, adjudicated, and shared with CDC and FDA scientists? What is the budget and who will oversee the research protocols? The CMS idea to reimburse VAERS reports will require formal rulemaking before it takes effect, and modernizing VAERS could lead to a surge of raw reports that still need careful review. Given HHS Secretary Kennedy’s public history on vaccines, skeptics worry this program could be politicized or used to fuel alarm if the agency does not publish clear methods and results.
Demand transparency, rigorous science, and real help for patients
Conservatives should be clear-eyed: it’s a win when government finally listens to patients who feel ignored. But applause should be cautious until HHS publishes clinic protocols, oversight plans, and a timeline for how findings will be reviewed and released. The best outcome is rigorous, transparent science that either identifies genuine safety issues that can be fixed or reassures the public that vaccines remain safe. Anything less — spin, secrecy, or partisan headlines — will squander the opportunity and make trust even harder to earn.
